Why Bristol-Myers Squibb is Down 7% Today

Not everyone is thrilled with clinical trial results released by Bristol-Myers Squibb (BMY) today at the annual meeting of the American Society of Clinical Oncology. The stock fell more than 7% to $64.24 amid concerns about data released today regarding the use of the drug Opdivo in patient suffering from the most common form of [...]